SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-034820
Filing Date
2024-04-22
Accepted
2024-04-22 13:13:14
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0204165-01.htm DEF 14A 1820059
2 GRAPHIC tproxy_001.jpg GRAPHIC 1354780
3 GRAPHIC tproxy_002.jpg GRAPHIC 1270160
  Complete submission text file 0001213900-24-034820.txt   5437176
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39138 | Film No.: 24860614
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)